The Role of Toll-like Receptor 4 in Irritable Bowel Syndrome
Author Information
Author(s): Wan Xuemeng, Wang Liyuan, Wang Zhiling, Wan Chaomin
Primary Institution: West China Second University Hospital of Sichuan University
Hypothesis
Toll-like receptor 4 (TLR4) plays a vital role in the development of irritable bowel syndrome (IBS).
Conclusion
TLR4 is significantly up-regulated in IBS, correlating with clinical manifestations, and various therapies targeting TLR4 can reduce IBS-related symptoms.
Supporting Evidence
- Clinical data showed that aberrant TLR4 expression is associated with pain and diarrhea in IBS.
- Many promising therapeutic options have improved IBS symptoms by targeting TLR4.
- TLR4 is involved in multiple pathogenic mechanisms of IBS, including inflammation and visceral hypersensitivity.
Takeaway
This study looks at how a specific protein, TLR4, is involved in a tummy problem called irritable bowel syndrome, and how treating it might help people feel better.
Methodology
A systematic review of literature was conducted using multiple databases to synthesize existing studies on TLR4 in IBS.
Potential Biases
Potential biases may arise from the variability in study designs and diagnostic criteria used across included studies.
Limitations
The review may be limited by the small sample sizes in individual studies and the heterogeneity of IBS symptoms.
Participant Demographics
The studies included a mix of genders and ages, with specific details on patient demographics varying by study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website